<table id="_Ref413920932" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2: Dose to body weight range to achieve similar steady-state exposure (AUC<sub>0-24hr</sub>) to unbound oxaprozin in JRA patients relative to 70 kg adult rheumatoid arthritis patients administered oxaprozin 1200 mg QD<sup>1</sup>
</caption>
<col width="45%"></col>
<col width="49%"></col>
<tfoot>
<tr>
<td align="left" colspan="2" stylecode="Botrule" valign="top">
<sup>1</sup> Model-based nomogram derived from unbound oxaprozin steady-state drug plasma concentrations of JRA patients weighing 22.1 kg to 42.7 kg or ≥45.0 kg administered oxaprozin 600 mg or 1200 mg QD for 14 days, respectively.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" stylecode="Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Dose (mg)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Body Weight Range</content>
</paragraph>
<paragraph>
<content stylecode="bold"> (kg)</content>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Lrule Botrule " valign="top">
<paragraph>600</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>22 - 31</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Lrule Botrule " valign="top">
<paragraph>900</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>32 - 54</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule Lrule " valign="top">
<paragraph>1200</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>≥55</paragraph>
</td>
</tr>
</tbody>
</table>